LONDON, July 26 (Reuters) - U.S. drugmaker Schering-Plough Corp. (SGP.N: Quote, Profile, Research) has withdrawn its application to European regulators for experimental antibiotic garenoxacin, the European Medicines Agency said on Thursday.
LONDON, July 26 (Reuters) - U.S. drugmaker Schering-Plough Corp. (SGP.N: Quote, Profile, Research) has withdrawn its application to European regulators for experimental antibiotic garenoxacin, the European Medicines Agency said on Thursday.